Sponsor
Jiangsu Cancer Institute & Hospital
Clinical research sponsor
Clinical trials
23 shownQUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast CancerNCT07601178 · lead sponsor · 2026-04-17
RECRUITINGA Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung CancerNCT07082179 · lead sponsor · 2025-09-04
RECRUITINGMRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLCNCT06198868 · lead sponsor · 2024-02-01
RECRUITINGStereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 TrialNCT07286942 · lead sponsor · 2025-12-18
NOT_YET_RECRUITINGPhase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC.NCT07009925 · lead sponsor · 2025-06-01
NOT_YET_RECRUITINGStudy of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLCNCT05782426 · lead sponsor · 2023-03-15
UNKNOWNChemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)NCT05784142 · lead sponsor · 2022-10-27
ACTIVE_NOT_RECRUITINGAn Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung CancerNCT03413956 · lead sponsor · 2017-12-01
COMPLETEDRATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLCNCT07541521 · collaborator · 2026-04-13
RECRUITINGDownstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLCNCT07528066 · collaborator · 2026-03-02
RECRUITINGLiquid Biopsy-Based Novel Modality for Postoperative Management of Lung CancerNCT06930807 · collaborator · 2025-03-25
RECRUITINGLobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)NCT06577792 · collaborator · 2023-08-16
ACTIVE_NOT_RECRUITINGAcupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL)NCT05069467 · collaborator · 2022-06-01
UNKNOWNctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLCNCT05198154 · collaborator · 2022-01-24
ACTIVE_NOT_RECRUITINGBreath Combined With CT for Diagnoses of Pulmonary NodulesNCT04948047 · collaborator · 2021-07-10
UNKNOWNRobot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)NCT06524427 · collaborator · 2020-08-25
ACTIVE_NOT_RECRUITINGDetecting Lung Cancer Based on Exhaled BreathNCT04419207 · collaborator · 2019-03-01
COMPLETEDDetection of Lung Cancer by Plasma LipidsNCT04287712 · collaborator · 2018-12-13
COMPLETEDRecombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLCNCT01733589 · collaborator · 2012-11-01
COMPLETEDErlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung CancerNCT01407822 · collaborator · 2011-12-05
UNKNOWNGefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR MutationNCT01405079 · collaborator · 2011-09-19
UNKNOWNIntercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung CancerNCT01404260 · collaborator · 2011-06-01
COMPLETEDModified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC)NCT01337037 · collaborator · 2011-04-01
UNKNOWNSponsor roles
collaborator15
lead sponsor8
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.